Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras - PubMed (original) (raw)
Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras
M W Mayo et al. Science. 1997.
Abstract
The ras proto-oncogene is frequently mutated in human tumors and functions to chronically stimulate signal transduction cascades resulting in the synthesis or activation of specific transcription factors, including Ets, c-Myc, c-Jun, and nuclear factor kappa B (NF-kappaB). These Ras-responsive transcription factors are required for transformation, but the mechanisms by which these proteins facilitate oncogenesis have not been fully established. Oncogenic Ras was shown to initiate a p53-independent apoptotic response that was suppressed through the activation of NF-kappaB. These results provide an explanation for the requirement of NF-kappaB for Ras-mediated oncogenesis and provide evidence that Ras-transformed cells are susceptible to apoptosis even if they do not express the p53 tumor-suppressor gene product.
Similar articles
- Impaired TNFalpha-induced A20 expression in E1A/Ras-transformed cells.
Huang HL, Yeh WC, Lai MZ, Mirtsos C, Chau H, Chou CH, Benchimol S. Huang HL, et al. Br J Cancer. 2009 Nov 3;101(9):1555-64. doi: 10.1038/sj.bjc.6605352. Epub 2009 Oct 13. Br J Cancer. 2009. PMID: 19826422 Free PMC article. - The p53 tumor suppressor gene and gene product.
Levine AJ. Levine AJ. Princess Takamatsu Symp. 1989;20:221-30. Princess Takamatsu Symp. 1989. PMID: 2488233 Review. - Activation of p53 by oncogenes.
Lowe SW. Lowe SW. Endocr Relat Cancer. 1999 Mar;6(1):45-8. doi: 10.1677/erc.0.0060045. Endocr Relat Cancer. 1999. PMID: 10732786 Review.
Cited by
- Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomas.
Li J, Sordella R, Powers S. Li J, et al. Sci Rep. 2016 Jun 15;6:27891. doi: 10.1038/srep27891. Sci Rep. 2016. PMID: 27301828 Free PMC article. - PTEN enhances TNF-induced apoptosis through modulation of nuclear factor-kappaB signaling pathway in human glioma cells.
Koul D, Takada Y, Shen R, Aggarwal BB, Yung WK. Koul D, et al. Biochem Biophys Res Commun. 2006 Nov 17;350(2):463-71. doi: 10.1016/j.bbrc.2006.09.077. Epub 2006 Sep 25. Biochem Biophys Res Commun. 2006. PMID: 17011514 Free PMC article. - Of the atypical PKCs, Par-4 and p62: recent understandings of the biology and pathology of a PB1-dominated complex.
Moscat J, Diaz-Meco MT, Wooten MW. Moscat J, et al. Cell Death Differ. 2009 Nov;16(11):1426-37. doi: 10.1038/cdd.2009.119. Epub 2009 Aug 28. Cell Death Differ. 2009. PMID: 19713972 Free PMC article. Review. - Identification of REPS2 as a putative modulator of NF-kappaB activity in prostate cancer cells.
Penninkhof F, Grootegoed JA, Blok LJ. Penninkhof F, et al. Oncogene. 2004 Jul 22;23(33):5607-15. doi: 10.1038/sj.onc.1207750. Oncogene. 2004. PMID: 15184881 - Natural biology of polyomavirus middle T antigen.
Gottlieb KA, Villarreal LP. Gottlieb KA, et al. Microbiol Mol Biol Rev. 2001 Jun;65(2):288-318 ; second and third pages, table of contents. doi: 10.1128/MMBR.65.2.288-318.2001. Microbiol Mol Biol Rev. 2001. PMID: 11381103 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous